Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis
Author(s) -
Shaghayegh Tavakoli Tabazavareh,
Aaron P. Seitz,
Peter L. Jernigan,
Carolin Sehl,
Simone Keitsch,
Stephan Lang,
Barbara C. Kahl,
Michael J. Edwards,
Heike Grassmé,
Erich Gulbins,
Katrin Anne Becker
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000445567
Subject(s) - staphylococcus aureus , sphingosine , ceramide , microbiology and biotechnology , cystic fibrosis , pseudomonas aeruginosa , respiratory tract , biology , medicine , respiratory system , immunology , bacteria , receptor , biochemistry , apoptosis , genetics
Pulmonary Staphylococcus aureus (S. aureus) infections occur early in a high percentage of cystic fibrosis (CF) patients and it is believed that these infections facilitate further colonization of CF lungs with Pseudomonas aeruginosa (P. aeruginosa). Previous studies demonstrated a marked reduction of sphingosine in tracheal and bronchial epithelial cells in CF compared to wild type mice, while ceramide is massively increased in CF mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom